The SPAPB1A11.02 Antibody targets the protein encoded by the SPAPB1A11.02 locus, which is homologous to Saccharomyces cerevisiae Kre9. This protein is essential for β-1,6-glucan synthesis, a key component of the fungal cell wall . Key features include:
Specificity: Recognizes epitopes within the Sup11p protein, a Schizosaccharomyces pombe ortholog involved in cell wall integrity .
Applications: Used in Western blotting, chromatin immunoprecipitation (ChIP-qPCR), and immunofluorescence to study protein localization and heterochromatin dynamics .
Validation: Demonstrated through functional assays showing loss of β-1,6-glucan in sup11 knockdown mutants .
Disruption of SPAPB1A11.02 via mRNA interference leads to complete absence of β-1,6-glucan in the cell wall, causing severe morphological defects and septum malformation .
The mutant accumulates aberrant β-1,3-glucan deposits at septa, implicating Sup11p in cross-linking glucan polymers .
SPAPB1A11.02 transcripts are upregulated under low-temperature stress (18°C), triggering facultative heterochromatin assembly via Clr4-mediated H3K9 methylation .
Key mechanism: mRNA from SPAPB1A11.02 recruits Clr4 to its own locus, forming a feedback loop to regulate gene expression (Fig. 3c–g) .
Heterochromatin formation at SPAPB1A11.02 is modulated by iron levels. Deletion of the iron sensor fep1 suppresses cold sensitivity in ccr4Δ mutants, linking iron metabolism to chromatin dynamics .
Cell Biology: Used to study fungal cell wall architecture and stress adaptation.
Epigenetics: Tools for mapping facultative heterochromatin under environmental stress.
Drug Development: Potential target for antifungals disrupting β-glucan synthesis.
SPAPB1A11.02 is a gene in Schizosaccharomyces pombe (fission yeast) that encodes a protein with potential functional similarities to its neighboring gene SPAPB1A11.01 (mfc1+). While SPAPB1A11.02 itself remains less characterized, the proximity to mfc1+ suggests potential involvement in membrane transport mechanisms. The mfc1+ gene encodes an MFS family membrane transporter that shows significant upregulation (17.2-fold) under copper-limiting conditions . This contextual information provides a starting point for investigating SPAPB1A11.02's potential role in cellular transport processes, particularly in response to metal availability fluctuations in the cellular environment.
When designing experiments to investigate SPAPB1A11.02 expression patterns, adhere to the three core principles of good experimental design: replication, randomization, and blocking . Include a minimum of 3-4 biological replicates per condition to ensure statistical validity. Given the significant expression changes observed in the related mfc1+ gene under copper-limiting conditions (17.2-fold increase) , consider examining SPAPB1A11.02 expression under various metal ion concentrations, particularly copper depletion using chelators like TTM (ammonium tetrathiomolybdate). Implement proper controls including wild-type strains under standard conditions, and potentially examine expression in parallel with known responsive genes like ctr4+, ctr5+, and ctr6+ that show differential expression under copper limitation .
SPAPB1A11.02 antibodies can be employed in several fundamental research applications including western blotting for protein expression quantification, immunoprecipitation to identify protein interaction partners, immunofluorescence microscopy for localization studies, and chromatin immunoprecipitation if the protein has DNA-binding properties. Based on the expression pattern of the neighboring gene mfc1+ in response to copper limitation , SPAPB1A11.02 antibodies may be particularly useful in studying stress responses in fission yeast, especially those related to metal homeostasis. These antibodies can help track changes in protein levels, modifications, and localization under various environmental conditions, providing insights into the protein's functional role in cellular processes.
Validating antibody specificity for SPAPB1A11.02 requires a multi-faceted approach. First, perform western blotting using wild-type S. pombe lysates alongside a knockout or CRISPR-edited strain lacking the SPAPB1A11.02 gene. The absence of the specific band in the knockout strain confirms specificity. Second, conduct peptide competition assays where the antibody is pre-incubated with the immunizing peptide before western blotting or immunostaining—signal reduction indicates specificity. Third, test cross-reactivity against recombinant proteins with similar sequences, particularly the neighboring gene product SPAPB1A11.01 (Mfc1), given its potential functional relationship . Finally, validate results using orthogonal methods such as mass spectrometry of immunoprecipitated proteins to confirm target identity.
Based on the significant upregulation (17.2-fold) of the neighboring SPAPB1A11.01 (mfc1+) gene under copper-limiting conditions , design a comprehensive set of conditions focusing on metal homeostasis. Include:
Copper limitation using chelators like TTM (ammonium tetrathiomolybdate)
Copper excess conditions
Other metal stress conditions (zinc, iron, manganese)
Oxidative stress conditions (H₂O₂, menadione)
Cell cycle synchronization to identify potential cell cycle-dependent expression
Meiotic induction conditions, as neighboring mfc1+ has been studied in the context of meiotic and forespore membrane processes
Compare these results with known copper-responsive genes like ctr4+, ctr5+, and ctr6+ to establish functional relationships within the copper homeostasis network .
When analyzing differential expression of SPAPB1A11.02, implement a rigorous statistical framework to avoid both Type I (false positive) and Type II (false negative) errors . Begin with power analysis to determine adequate sample size, aiming for at least 3-4 biological replicates per condition. Normalize expression data appropriately, considering both within-sample normalization (to control genes) and between-sample normalization methods. For significance testing, apply appropriate statistical tests such as t-tests for simple comparisons or ANOVA for multiple conditions, with post-hoc tests as needed. Implement multiple testing correction (e.g., Benjamini-Hochberg) to control false discovery rates, especially when analyzing across multiple conditions. When reporting fold-changes, include both the statistical significance (p-value) and the magnitude of change, similar to how the 17.2-fold change was reported for mfc1+ in copper-limited conditions .
To investigate the potential functional relationship between SPAPB1A11.02 and mfc1+ (SPAPB1A11.01), implement a multi-layered experimental approach. First, generate single and double deletion mutants to assess genetic interaction through phenotypic analysis, particularly under copper-limiting conditions where mfc1+ shows strong upregulation (17.2-fold) . Second, perform reciprocal co-immunoprecipitation experiments using antibodies against both proteins to detect physical interactions. Third, employ proximity labeling methods (BioID or APEX) to identify the broader interaction networks of both proteins. Fourth, conduct transcriptional profiling of each deletion mutant to identify overlapping gene expression signatures. Fifth, use fluorescently-tagged versions of both proteins to assess co-localization through high-resolution microscopy. Finally, perform complementation experiments where each gene is expressed in the other's deletion background to test for functional redundancy.
For effective localization studies of SPAPB1A11.02 protein, implement both fixed and live-cell imaging techniques. Create a C-terminal or N-terminal fluorescent protein fusion (GFP or mCherry) under the native promoter, being careful not to disrupt functional domains. For co-localization studies, pair with established markers such as Sad1-Cherry for spindle pole body or GFP-Psy1 for forespore membrane, similar to the approach used in mfc1+ studies . Implement time-lapse confocal microscopy during key cellular transitions, particularly copper starvation responses, cell division, and meiosis. For higher resolution, apply super-resolution techniques such as STED or PALM microscopy. Complement imaging with biochemical fractionation to confirm subcellular localization independently. When analyzing localization data, quantify signal intensity across cellular compartments and time points using appropriate image analysis software, and report statistical measures of colocalization when applicable.
To comprehensively understand SPAPB1A11.02 function within copper homeostasis networks, implement an integrated multi-omics approach. Begin with RNA-seq under copper-limited and copper-replete conditions, similar to the experiments that identified mfc1+ upregulation , ensuring proper experimental design with adequate replication and controls . In parallel, perform quantitative proteomics (TMT or SILAC) to identify changes at the protein level that may differ from transcriptional responses. Expand the analysis to include phosphoproteomics to detect post-translational regulation. Compare the SPAPB1A11.02 deletion strain with wild-type to identify dysregulated pathways. Integrate these datasets using pathway analysis tools to map functional networks. To validate key findings, perform targeted experiments such as ChIP-seq to identify transcription factors regulating SPAPB1A11.02 and related genes, particularly under copper stress conditions. Finally, construct a systems-level model incorporating transcriptional, translational, and post-translational regulatory mechanisms governing SPAPB1A11.02 and other copper-responsive genes.
When performing immunoprecipitation with SPAPB1A11.02 antibodies, several technical challenges require careful consideration. First, optimize lysis conditions to effectively solubilize the protein while maintaining native interactions—if SPAPB1A11.02 is membrane-associated like mfc1+ , standard RIPA buffers may disrupt important interactions. Instead, try milder detergents like digitonin or CHAPS. Second, implement proper negative controls including IgG control antibodies and ideally a SPAPB1A11.02 knockout strain. Third, be aware of potential cross-reactivity with related proteins, particularly SPAPB1A11.01 (mfc1+) given its proximity and potential functional relationship . Fourth, consider the timing of sample collection, particularly if expression is condition-dependent like the copper-responsive genes identified in previous studies . Finally, validate IP efficiency through western blotting before proceeding to downstream applications like mass spectrometry, and optimize antibody concentration to minimize background while maintaining sufficient pull-down efficiency.
Batch effects can significantly confound experimental results when working with antibodies. To minimize these effects, implement a comprehensive experimental design following the principles of replication, randomization, and blocking . First, purchase sufficient antibody from the same lot for the entire experimental series, as different production batches may have varying affinities or specificities. Second, prepare and aliquot all buffers and reagents in advance to ensure consistency across experiments. Third, design experiments to include samples from all treatment conditions within each experimental batch rather than processing different conditions on different days. Fourth, include technical replicates to assess intra-assay variation and biological replicates to capture natural biological variation. Fifth, incorporate positive controls (samples with known SPAPB1A11.02 expression) and negative controls (knockout strains) in each batch. Finally, when analyzing data, apply appropriate statistical methods to identify and correct for batch effects, such as ComBat normalization for high-throughput data or mixed-effects models that explicitly include batch as a random effect.
For accurate quantification of SPAPB1A11.02 protein levels under different stress conditions, implement a comprehensive methodological approach. First, establish a standardized protein extraction protocol optimized for membrane-associated proteins, considering that related proteins like mfc1+ function as membrane transporters . Second, select appropriate quantification methods—western blotting with fluorescent secondary antibodies offers a wider linear range than chemiluminescence, while mass spectrometry-based approaches like selected reaction monitoring (SRM) provide absolute quantification. Third, include multiple internal loading controls beyond standard housekeeping proteins, preferably proteins whose expression is verified to remain stable under your specific stress conditions. Fourth, implement technical triplicates and at least 3-4 biological replicates per condition . Fifth, design time-course experiments to capture dynamic responses, particularly important given the significant expression changes observed in related genes under copper limitation . Finally, apply appropriate statistical analyses, including normalization methods that account for total protein loading (e.g., stain-free technology) rather than relying solely on single reference genes that may themselves be stress-responsive.
CRISPR-Cas9 technology offers powerful approaches for investigating SPAPB1A11.02 function in S. pombe beyond traditional deletion methods. First, implement precise gene editing to create point mutations in specific domains to dissect protein function while maintaining expression. Second, use CRISPR interference (CRISPRi) with catalytically dead Cas9 to achieve tunable repression of SPAPB1A11.02 expression, allowing temporal control over gene silencing. Third, apply CRISPR activation (CRISPRa) to upregulate expression and assess gain-of-function phenotypes. Fourth, create knock-in fluorescent tags at the endogenous locus to visualize native protein expression and localization without plasmid overexpression artifacts. Fifth, generate specific mutations that mimic those in related genes like SPAPB1A11.01 (mfc1+) to test functional conservation. Finally, implement multiplex CRISPR to simultaneously target SPAPB1A11.02 and related genes to uncover genetic interactions and redundancies within the copper homeostasis network identified in previous studies .
To investigate SPAPB1A11.02 evolution and conservation, implement a systematic comparative genomics strategy. First, perform comprehensive sequence homology searches across diverse fungal lineages, extending beyond the Schizosaccharomyces genus to identify orthologs and paralogs. Second, conduct synteny analysis to determine if the genomic organization surrounding SPAPB1A11.02 is conserved, particularly its proximity to SPAPB1A11.01 (mfc1+) , which might indicate functional relationships maintained through evolution. Third, apply selection analysis (dN/dS ratios) to identify regions under purifying or positive selection. Fourth, perform structural prediction and comparison of the protein domains across species to identify conserved functional motifs. Fifth, compare expression patterns of orthologs in response to copper limitation across species, given the significant upregulation observed in the neighboring mfc1+ gene . Finally, implement ancestral sequence reconstruction to infer the evolutionary trajectory of SPAPB1A11.02 and related transport proteins, providing insights into functional adaptation to different cellular requirements for metal homeostasis.
Single-cell technologies offer unprecedented insights into cell-to-cell variability in SPAPB1A11.02 expression and function. First, apply single-cell RNA sequencing (scRNA-seq) to capture expression heterogeneity across thousands of individual cells under various conditions, particularly during copper limitation where related genes show significant upregulation . Second, implement single-cell proteomics through mass cytometry (CyTOF) using metal-conjugated SPAPB1A11.02 antibodies to quantify protein levels at single-cell resolution. Third, develop a SPAPB1A11.02 transcriptional reporter system using unstable fluorescent proteins to enable live-cell imaging of dynamic expression changes. Fourth, combine microfluidics with time-lapse microscopy to track expression in lineages of cells exposed to fluctuating copper concentrations. Fifth, apply spatial transcriptomics to map SPAPB1A11.02 expression within colonies or multicellular structures. Finally, integrate these single-cell datasets with computational modeling to predict how expression heterogeneity influences population-level responses to environmental stresses, particularly in the context of metal homeostasis networks identified in previous studies .